We narrowed to 18,124 results for: Ret;

#132159

Gateway entry clone with codon-optimized ORF sequence for subcloning into custom expression vectors

RESOLUTE Consortium, Giulio Superti-Furga

Superti-Furga et al Nat Rev Drug Discov. 2020 Jul;19(7):429-

Oct. 22, 2019

Industry, Academic Institutions, and Nonprofits

#132004

Gateway entry clone with codon-optimized ORF sequence for subcloning into custom expression vectors

RESOLUTE Consortium, Giulio Superti-Furga

Superti-Furga et al Nat Rev Drug Discov. 2020 Jul;19(7):429-

Oct. 24, 2019

Industry, Academic Institutions, and Nonprofits

#161311

Gateway entry clone with codon-optimized ORF sequence for subcloning into custom expression vectors. Contains a STOP codon at the end of the codon-optimized ORF sequence.

RESOLUTE Consortium, Giulio Superti-Furga

Superti-Furga et al Nat Rev Drug Discov. 2020 Jul;19(7):429-

Sept. 15, 2021

Industry, Academic Institutions, and Nonprofits

#161264

Gateway entry clone with codon-optimized ORF sequence for subcloning into custom expression vectors. Contains a STOP codon at the end of the codon-optimized ORF sequence.

RESOLUTE Consortium, Giulio Superti-Furga

Superti-Furga et al Nat Rev Drug Discov. 2020 Jul;19(7):429-

Sept. 15, 2021

Industry, Academic Institutions, and Nonprofits

#163359

Lentiviral vector for negative control of knockdown expressing a non-target miR against Renilla luciferase, with expression of a Ly6G surface marker and a puromycin selection marker.

Louis Ates, Teunis Geijtenbeek

van der Donk et al Biol Open. 2022 Feb 15;11(2):bio059032.

Jan. 15, 2021

Academic Institutions and Nonprofits only

#132108

Gateway entry clone with codon-optimized ORF sequence for subcloning into custom expression vectors

RESOLUTE Consortium, Giulio Superti-Furga

Superti-Furga et al Nat Rev Drug Discov. 2020 Jul;19(7):429-

Dec. 4, 2019

Industry, Academic Institutions, and Nonprofits

#132132

Gateway entry clone with codon-optimized ORF sequence for subcloning into custom expression vectors

RESOLUTE Consortium, Giulio Superti-Furga

Superti-Furga et al Nat Rev Drug Discov. 2020 Jul;19(7):429-

Nov. 25, 2019

Industry, Academic Institutions, and Nonprofits

#132120

Gateway entry clone with codon-optimized ORF sequence for subcloning into custom expression vectors

RESOLUTE Consortium, Giulio Superti-Furga

Superti-Furga et al Nat Rev Drug Discov. 2020 Jul;19(7):429-

Nov. 21, 2019

Industry, Academic Institutions, and Nonprofits

#132086

Gateway entry clone with codon-optimized ORF sequence for subcloning into custom expression vectors

RESOLUTE Consortium, Giulio Superti-Furga

Superti-Furga et al Nat Rev Drug Discov. 2020 Jul;19(7):429-

Nov. 21, 2019

Industry, Academic Institutions, and Nonprofits

#132060

Gateway entry clone with codon-optimized ORF sequence for subcloning into custom expression vectors

RESOLUTE Consortium, Giulio Superti-Furga

Superti-Furga et al Nat Rev Drug Discov. 2020 Jul;19(7):429-

Nov. 19, 2019

Industry, Academic Institutions, and Nonprofits